Lataa...
TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates
The purpose of this study was to characterize the antiviral activity, cytotoxicity, and mechanism of action of TMC114, a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI). TMC114 exhibited potent anti-HIV activity with a 50% effective concentration (EC(50)) of 1 to 5 nM and a...
Tallennettuna:
Päätekijät: | , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
American Society for Microbiology
2005
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1140553/ https://ncbi.nlm.nih.gov/pubmed/15917527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.6.2314-2321.2005 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|